Earnings Releases·Nov 5, 2026, 4:20 PM ET

Nu Skin Enterprises — Third Quarter 2026 Earnings Summary

Q3 2026 revenue declined 14.6% year-over-year to $311.0 million, driven by a 19.2% drop in the Nu Skin segment and a 18% decrease in customer count, resulting in a GAAP EPS loss of $(0.02) versus $0.34 in the prior year.
Full-year 2026 revenue guidance was maintained at $1.26 billion to $1.29 billion (a 13% to 15% decline), with Q4 revenue projected between $310 million and $340 million and adjusted EPS expected between $0.11 and $0.21.
The company reported a net loss of $248.7 million for the first nine months of 2026 compared to prior-year net income, impacted by $80.7 million in impairment expenses and $8.9 million in other charges, while cash reserves decreased to $164.9 million.
Strategic initiatives include growing Rhyz revenue (up 13.2% to $58.4 million) and the adoption of the Prysm iO platform, alongside new anti-aging product launches, though the company faces significant regulatory and competitive headwinds in key markets.
Capital allocation remained conservative with no stock repurchases in the quarter and $2.9 million in dividend payments, leaving $137.3 million remaining in the stock repurchase authorization.